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In contrast to untransformed cells the microenvi-
ronment of malignant cells in tumor is characterized 
by the deficiency of nutrient substrates (oxygen, glu-
cose, amino acids etc.) and by accumulation of waste 
products of tumor cells. Arising in the conditions of 
oxygen deficiency in tumor due to the insufficient level 
of vascularity the metabolic stress is followed by the 
accumulation of reactive oxygen species (ROS) that 
display the damaging activity towards macromolecules 
and biological membranes, from the one hand, and 
stand as the regulatory components of signal pathways 
that regulate proliferation, differentiation, apoptosis, 
autophagy and neoangiogenesis etc., from the other 
hand [1–3, 6, 8, 10, 21]. Thereby on the background of 
metabolic stress the survival of tumor cells substantion-
ally depends on the functioning of antioxidant system 
involved in the regulation of prooxidant processes 
intensity. The maintenance of the prooxidant–anti-
oxidant balance and the regulation of ROS content is 
realized in the cell in response to metabolic stress by 
the functioning of multi-level systems of enzymatic and 
non-enzymatic antioxidant defenses [9]. Glutathione-
dependent system belongs to the key components 
of antioxidant defense system that take part not only 
in neutralization of lipoperoxides but also play an im-
portant role in the regulation of functional activity of 
mitochondrial antiapoptotic proteins (Bcl-2 family) and 
in irreversible inactivation of protein kinase C [27, 29]. 
The key constituent of glutathione system is glutathione 
(γ-glutamil-L-cysteinyl-glycine), the intracellular pool of 
which includes the reduced (GSH) and oxidized (GSSG) 
forms, compound bisulfides (GS-S) and thioesters [7, 
23]. GSH/GSSG ratio maintained due to the activity 
of these enzymes is accepted to be considered as an 
important index of intracellular redox-state. The avoid-
ance of redundant ROS accumulation in the cells oc-
curs owing to the functioning of selenium-dependent 
(for H2O2) and selenium-independent (for organic 
peroxides) glutathione peroxidases [17]. Glutathione 
reductase provides the reduction of GSSG using 
NADPH and regulates the amount of substrate acces-
sible for gluthatione-S-transferase and glutathione 
peroxidase [15]. Catalase (E. C. 1.11.1.6) possesses 
the similar to glutathione peroxidase functional activity 
and is localized in peroxysomes in the form of tetrameric 
haemoprotein decomposing hydrogen peroxide that 
is known to cause the direct induction of Atg proteins 
expression and to stimulate the autophagic cell death 
[11, 13, 30]. The regulation of this enzyme’s activity by 
the modifications of the active or regulatory sites and 
by the selective degradation of catalase is pivotal in 
autophagy induction as one of the adaptive mecha-
nisms in response to the nutrients deficiency at the 
high requirements in the energy supply of vital functions 
[30]. In this connection, the study of functional activity 
of antioxidant system is important for the establishment 
of the possible mechanisms of adaptation and survival 
of tumor cells in the conditions of permanent hypoxia 
and nutrients deficiency.
The aim of our study was to evaluate the connection 
between the indices of functional activity of glutathi-
one-dependent enzymes in tumors of two Lewis lung 
carcinoma variants and the sensitivity of these tumors 
to metabolic stress.
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MATERIALS AND METHODS
The experiments were performed using 20 males 
of mice in the age of 2–2.5 months with the weight of 
18–23 g. All experimental procedures were conducted 
following the normative rules of bioethics. In the study 
the tumor cells of two variants of Lewis lung carcinoma 
were used. The variants differ in the sensitivity to the 
deficiency of nutritive substrates: (i) the cells of the 
wild-type of Lewis lung carcinoma (LLC) are resistant 
to the metabolic stress; (ii) the cells of modified variant 
of carcinoma (LLC/R9) display the higher sensitivity to 
low level of nutrients (in comparison with LLC) [18, 24]. 
Tumor cells were cultivated in RPMI-1640 (“Sigma”, 
USA) with addition of 10% EFS (“Sigma”, USA), 2 mM 
L-glutamine and 40 μg/ml gentamycin at +37 °C in hu-
mid conditions with 5% CO2. Then cells were inoculated 
to mice in the muscle of dextra thigh in the amount of 
1·106 cells in 0.1 ml of Haenks’ solution per animal.
On the 24th day after tumor transplantation the 
euthanasia of animals under the light ester anes-
thetic was performed. Tumors and thigh muscles 
(CMT — control muscle tissue) were removed. Since 
tumor cells were transplanted into thigh muscle of the 
analogous tissue without tumor was considered as the 
control tissue. As the control tissue the muscle tissue 
from the thigh of intact mice was used (IMT — intact 
muscle tissue). Tumors and muscle tissues were ho-
mogenized and the samples of tissue extracts were 
obtained by the centrifugation (16000 rpm, +4 °C).
The content of protein was determined with the 
technique developed by Greenberg [4]. In the tissue 
extracts the activity of antioxidant enzymes and the 
level of primary and secondary products of lipid per-
oxidation were evaluated.
The activity of glutathione peroxidase (GP) was 
determined using the method described in [28] and 
based on the determination of accumulated oxidized 
glutathione level.
The activity of glutathione reductase (GR) was 
evaluated in the reaction of reduction of oxidized glu-
tathione [28] by the determining the rates of NADPH 
decrease.
The activity of total glutathione-S-transpher-
ase (GST) was assessed using the kit (“Sigma”, USA) 
in the reaction of reduced glutathione with 1-chloro-2, 
4-dinitrobenzene by the measurement of rate of 
glutathione-S-2, 4-dinitrobenzene (GDNB) generation 
that is characterized with the absorbance maximum 
at 340 nm [14].
Activity of catalase (Cat) in tumors and muscle 
tissues was evaluated by the method [12] based on 
measurement of decrease of the complexes of am-
monium molibdate and hydrogen peroxide.
The determination of lipid peroxidation (LP) 
byproducts. The level of diene conjugates (DC) was 
determined by the rate of appearance of new maximum 
(233 nm) in the absorbance spectrum of polyunsatu-
rated fatty acids after the diene conjugation in the pro-
cedure described in [25]. The content of tiobarbiturate-
active products (TBAP) was evaluated accordingly to 
[26] in the reaction with tiobarbituric acid.
Statistical analysis. The results of investigations 
were analyzed using the common approaches of varia-
tion statistics. The level of significance of the differ-
ences between the groups was evaluated by the use 
of non-parametric Mann — Whitney U-test (р < 0.05).
RESULTS
Glutathione-dependent activities in LLC and LLC/
R9 tumors, in CMT and IMT of mice are represented 
in Tables 1, 2, respectively. The results represented on 
Fig. 1 point out the absence of significant changes in the 
activity of GP in CMT of mice with LLC/R9 tumors com-
paratively to the CMT of mice with LLC tumors and to IMT.
Таble 1. Activity of antioxidant enzymes in control muscle tissues of mice 
with transplanted tumors LLC and LLC/R9 and in muscle tissue of intact mice
Object
Characteristics
Activity of 
GSТ, micromol 
GDNB/mg of 
protein per min
Activi-
ty of GP, 
micromol 
GSSG/mg 
of protein 
per min
Activity of Cat, 
U/mg of pro-
tein per min
Activity of 
GR, micro-
mol NADPH/
mg of pro-
tein per min
Control mus-
cle tissue of 
mice with LLC
1204.1 ± 
570.3*
97.8 ± 17.0 7.6 ± 1.4* 1.8 ± 0.8*
Control muscle 
tissue of mice 
with LLC/R9
1994.1 ± 656.8 71.7±22.5 26.8 ± 3.9*,** 16.9 ± 11.3**
Muscle tissue 
of intact mice
3938.7 ± 672.2 80.5±16.5 193.5 ± 15.5 23.8 ± 12.8
Note: *differences are significant in comparison with the values of charac-
teristics for IMT (p < 0.05); **differences are significant in comparison with 
the values of characteristics for LLC (p < 0.05).
Таble 2. Activity of antioxidant enzymes in LLC and LLC/R9 tumors and in 
muscle tissue of intact mice
Object
Characteristics
Activity of GSТ, 
micromol GDNB/
mg of protein 
per min
Activity of 
GP, micro-
mol GSSG/
mg of protein 
per min
Activity of 
Cat, U/ mg 
of protein 
per min
Activity of 
GR, mi-
cromol 
NADPH/mg 
of protein 
per min
LLC tumors 840.2 ± 153.3* 191.4 ± 28.2* 35.6 ± 15.9* 0.75 ± 0.3*
LLC/R9 tumors 2241.5 ± 656.0** 67.2 ± 22.0** 18.8 ± 3.7* 7.9 ± 2.6**
Muscle tissue 
of intact mice
3938.7 ± 672.2 80.5 ± 16.5 193.5 ± 15.5 23.8 ± 12.8
Note: *differences are significant in comparison with the values of charac-
teristics for IMT (p < 0.05); **differences are significant in comparison with 
the values of characteristics for LLC (p < 0.05).
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Fig. 1. The activity of glutathione peroxidase in tumors and 
control muscle tissue of tumor bearing mice (2 — LLC; 3 — LLC/
R9) and in muscle tissue of intact mice (1)
Experimental Oncology 32, 249–253, 2010 (December) 251
However, the decrease in the value of this enzyme 
activity by 41% (р < 0.05) is observed in LLC/R9 tu-
mors in contrast to LLC tumors (Table 2).
In contrary to GP, the level of Cat activity which is 
mostly localized in peroxysomes (but acts synergis-
tically with GP towards transformation of hydrogen 
peroxide) was significantly decreased, as compared 
to IMT, in tumors of both types (original and modi-
fied variants of Lewis lung carcinoma) (Table 2). The 
level of Cat activity in CMT of LLC-bearing mice was 
equal to that of LLC tumors while the level of this 
enzyme activity was low, what was not characteristic 
for LLC/R9 tumors, compared to respective CMT 
(Table 1). Meanwhile Cat activity in the tumors didn’t 
differ significantly along with observed tendency 
toward the decrease of this index in LLC/R9 tumors 
compared to LLC tumors (Table 2).
As an indicator of prooxidative processes inten-
sity that is in relationship with the level of functioning 
of peroxidase chain in cells, the indexes reflecting 
LP intensity have been used. In LLC/R9 tumors and 
in CMT of these animals, a significant (p < 0.05) 
elevation of content of primary LP products com-
pared to respective studied objects of mice with 
transplanted LLС cells has been observed, while 
the tissues didn’t differ significantly by TBAP con-
tent (Fig. 2, 3). Comparative analysis of LP intensity 
indexes in tissues of mice with transplanted tumors 
and in IMT has evidenced on the increase (p < 0.05) 
of content of the products of diene conjugation of 
fatty acids in LLC/R9 tumors and in CMT of the mice, 
and on increase (p < 0.05) of content of secondary 
LP products in CMT of mice with LLС tumors com-
pared with IMT, that could point on intensification of 
free radical oxidation of lipid components in organi-
sm of animals with transplanted tumors [1, 23].
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Fig. 2. The content of diene conjugates in tumors and control 
muscle tissues of tumor bearing mice (2 — LLC; 3 — LLC/R9) 
and in muscle tissue of intact mice (1)
In the studied tissues of mice with transplanted 
tumors the decrease of GP level compared to IMT, 
has been detected. However, the enzyme activity in 
LLC/R9 tumors and in CMT of the mice compared 
to respective tissues of mice with transplanted LLС 
cells, was significantly (p < 0.05) increased and 
nearly reached the activity level in IMT (Table 1, 
Table 2). An activity of total pool of glutathione-S-
transferase in CMT of all tumor-bearing animals 
didn’t differ, and was decreased compared with 
its activity in IMT (Fig. 4). In LLC/R9 tumors, GST 
activi ty was elevated (p < 0.05) compared to the 
tumors of original variant LLC.
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Fig. 3. The content of tiobarbiturate-active products in tumors 
and control muscle tissues of tumor bearing mice (2 — LLC; 
3 — LLC/R9) and in muscle tissue of intact mice (1)
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Fig. 4. The activity of total glutathione-S-transpherase in tumors 
and control muscle tissue of tumor bearing mice (2 — LLC; 3 — 
LLC/R9) and in muscle tissue of intact mice (1)
DISCUSSION
The scheme presented on Fig. 5 reflects the rela-
tion and contingence of functioning of glutathione-
dependent enzymes, catalase, and superoxide 
dismutase for maintenance of prooxidant-antioxi-
dant balance of cell. The scheme demonstrates 
that for enzymatic activity, glutathione peroxidase 
and glutathione-S-transferase use the same sub-
strate — reduced glutathione (GSН), the pool of 
which is renewed via activity of NADPH-dependent 
glutathione reductase. Due to the action of glu-
tathione peroxidase, that is a key component of 
deactivation of cytotoxic hydroperoxides, the 
oxidation of reduced glutathione occurs, and this 
process is accompanied by reduction of cytotoxic 
peroxide compounds, while at the II-nd stage of 
cell detoxication glutathione-S-transferase utilizes 
reduced glutathione in the reactions of conjugation 
of xenobiotics of exogenous and endogenous origin 
metabolized on endoplasmic reticulum membranes 
with the involvement of cytochrome Р-450.
Taking into account the contingency of functioning 
of glutathione-dependent — GP and GST that use the 
same substrate — reduced glutathione, and also GR, 
with the involvement of which the pool of the latest is 
replenished (Fig. 5), the revealed differences between 
the indexes of enzymatic activities of glutathione 
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system in LLC/R9 tumors and in CMT of the mice and 
respective tissues of mice with LLC tumors (Table 1, 2), 
evidence on more effective functioning of GST in LLC/
R9 tumors; at the II-nd stage of detoxication GST is 
able to provide conjugation of xenobiotics, including 
medicinal means with the use of reduced glutathione, 
therefore providing the formation of mechanisms of 
drug resistance [27]. In CMT of mice with transplanted 
LLC/R9 tumors reduced GSН is used more effectively 
for oxidation of hydroperoxides of fatty acids, and 
hydrogen peroxide with the involvement of GP. Higher 
level of functional activity of GP in LLC/R9 tumors 
compared to studied tissues of mice with LLC tumors, 
evidences on effective renewal of oxidized glutathione 
form in tissues of LLC/R9 mice and supplement of 
substrate pool of GP and GST [15].
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Fig. 5. The interrelation of functional activity of the key antioxi-
dant enzymes
The presented results may be explained, among 
other reasons, by biological properties of LLC/R9 cell 
subline generated by experimental progression of LLC 
in the direction of formation of the resistance to cis-
dichlorodiaminoplatine. Possibly, the formation of drug 
resistance in LLC/R9 tumors may be a consequence 
of induction of GST isoform that differs (in particular, 
by substrate specificity) from the molecular form 
expressed constitutively in tissues of intact animals. 
Also, it is possible that in tumors and in tissues of 
tumor-bearing mice the suppression of expression/
activity of constitutively expressed form may occur 
as well [31]. The decrease or sometimes stable level 
of GST activity in CMT of mice with transplanted LLC 
tumors compared to IMT of mice could be explained 
by manifestation of tumor influence on organism.
The decrease (p < 0.05) of GP activity level in LLC/
R9 tumors compared with LLC tumors (Fig. 1), may 
occur via depletion of reaction substrate — GSН, and 
also potential impact of accumulated ROS into the 
process of oxidative modification of active site and its 
allosteric regulatory centers could not be excluded 
[16], and this is in accordance with significantly higher 
DC level (Fig. 2) in CMT of mice with LLC/R9 tumors 
and in LLC/R9 tumors. However, elevation of functional 
activity of GP excludes the possibility of suppression 
of its activity via the shift of GSH/GSSG ratio in cell 
toward increased content of oxidized GSSG form that 
couldn’t be used effectively by enzyme. GP activity in 
CMT preparations of mice with LLC/R9 tumors didn’t 
differ significantly from the intensity of this index in IMT.
However, in LLC/R9 tumors GP activity was by 41% 
lower (p < 0.05) than that in LLC tumors (Table 1). This 
could point on the fact that utilization of reduced 
glutathione in LLC tumors occurs at larger extent for 
detoxification of endogenous peroxides by glutathione 
peroxidase, what in turn may lead to lower sensitivity 
of LLC cells to metabolic stress.
The decrease of Cat activity in mice with LLC tu-
mors and in tumors of both variants compared to IMT 
(Table 1, 2) evidences on depletion of the enzyme 
activity in tissue of mice with LLC tumors; among pos-
sible reasons, oxidative modification of enzyme active 
site could be considered [16], what is in accordance 
with higher level of LP intensity (Fig. 3). Higher level of 
Cat activity (p < 0.05) that is a characteristic for LLC 
tumors in comparison with respective CMT has not 
been detected in LLC/R9 tumors in comparison with 
the respective CMT. Taking into account the data on 
more expressed level of autophagy-associated death 
for LLC/R9 tumor cells in vitro compared to wild-type 
LLC cells, one may suppose that the compensatory in-
crease of Cat activity (p < 0.05), that has been observed 
in LLC tumors versus respective CMT, has been leveled 
down in LLC/R9 tumors by processes of selective Cat 
degradation, a key initial step of autophagy [22, 29]. 
The registered decrease of Cat activity is in accordance 
with the data of other authors who have detected such 
patterns: the drop of the enzyme activity by 75–90% in 
malignant transformed keratinocytes correlated with 
manifestations of malignant phenotype of these cells 
[19]; negative transcription regulation of catalase gene 
in human hepatoma cells has been revealed, and this 
may point on possible role of regulatory mechanisms 
on transcription level [20]; Cat activity is significantly 
decreased in liver tissue of tumor-bearing rats, but after 
tumor removal returns to normal level [5].
The detected increase (p < 0.05) of DC content in 
CMT and LLC/R9 tumors versus CMT of mice with LLC 
tumors evidences on intensified primary LP reactions 
compared with secondary ones, due to elevation of the 
quantity of radicals able initiate conversion of fatty acids 
in the content of membrane lipids in LLC/R9 tumors.
As far as we have studied the tumors developed after 
transplantation of LLC and LLC/R9 variants — the cells 
of the same tissue origin and genotype, but differing by 
a number of phenotypic patterns, it seems to be cor-
rect to establish a relation between antioxidant enzyme 
activity and biological properties of the tumors.
So, the tumors developed after transplantation 
of wild-type strain of Lewis lung carcinoma that are 
chara cterized by tolerance for metabolic stress and 
high metastatic potential [18, 24], are also charac-
terized by higher level of functioning of peroxidase 
enzymes (GP and Cat) at the background of higher LP 
intensity, associated with accumulation of secondary 
lipid peroxidation products, but lower levels of GST 
and GR activities in comparison with LLC/R9 tumors.
Experimental Oncology 32, 249–253, 2010 (December) 253
The sensitivity of LLC/R9 cells to deficiency of nutri-
ent substrates is correlated with high GSТ activity level, 
higher GR activity, and higher intensity of primary LP 
processes. The latest is related to the lower volume of 
pool of free radical molecules able initiate chain reac-
tions of oxidation at the background of lower level of 
functional activity of peroxidase enzymes.
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